A previous study showed that CBD alleviated hepatic steatosis and oxidative stress and significantly decreased the expression of NF-κB, NLRP3, ASC, procaspase-1, caspase-1 p20, GSDMD, and cleaved GSDMD both in vivo and in vitro. Here, CASP1 is linked to fatty liver disease.